Trends in 2017
What will be the most dominant business trends in the pharmaceutical sector in the year ahead?
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Cover Story
Increasing access to medicines via collaboration and digitisation
A Vaidheesh, VP, South Asia and MD, India, GlaxoSmithKline Pharmaceuticals, in an exclusive interaction with Prathiba Raju…
Where the mind is without fear…
TK Kanchana, Director-General, Organisation of Pharmaceutical Producers of India (OPPI) talks about the trends which are most…
A year of opportunities and challenges
Vikas Bhadoria, Senior Partner, Mc Kinsey and Vivek Arora, Associate Partner, Mc Kinsey, talk about how the global industry is at…
Business trends in 2017
Utkarsh Palnitkar, Partner, National Head – Infrastructure, Government & Healthcare and National Head – Life Sciences…
Dominant business trends in 2017
Ameesh Masurekar, Director, AIOCD Pharmasofttech AWACS, talks about the prevalence of online retail, therapeutic and regulatory…
Indian pharma landscape in 2017
Antal International takes a closer look at the business trends that could be game changers for India's growing pharmaceutical…
Pharma cos need to realign biz models
Pharma companies should focus on high-performing therapeutic area and geographic markets and they need to realign their business…
Fixed dose combination drugs – to be banned or not to be banned
Ajay Bhargava, Vanita Bhargava and Aseem Chaturvedi explain how the FDC ban notification has adversely affected the pharma…
Trends in global and Indian pharma industry
Uttam Jain, Director, Neon Laboratories, elaborates on how the pharma industry will register positive growth trends in the next…
Pharma cos brace up for a paradigm shift
With vast and quick change in culture and various global platforms, the industry is to witness a growing trend of digitisation in…
Outlook for global medicines through 2021
Growth in spending on medicines in major pharmerging markets has slowed from 2–10 percentage points over the past five years and…
Experts examine the strategies for a new VUCA WORLD
Featuring
- Jawed Zia, Novartis India
- Mike Warmuth, Abbott
- Daara Patel, IDMA
- Dr Ajit Dangi, Danssen Consulting
- Utkarsh…
Embracing change: Crucial to success in a VUCA world
Jawed Zia, Country President, Novartis India, advises pharma leaders to constantly evaluate their skills and course correct to…
India: The pulse of healthcare in emerging economies
India was among the first countries in which Abbott expanded outside the US, way back in 1910. Today, more than 85 per cent of…
The pharma industry worldwide is facing severe challenges that it has never faced before
Titans of the pharma industry are adjusting their sails to adapt to an increasingly VUCA world where volatility, uncertainty,…
Navigating through turbulent waters
Dr Ajit Dangi, President & CEO Danssen Consulting, shares his tips for pharma leaders to operate and thrive in a VUCA world…
Trends and challenges in a VUCA world
Utkarsh Palnitkar, Partner, National Head – Infrastructure, Government & Healthcare National Head – Life Sciences practice,…
Leadership strategy to SAVE clinical trials in India from VUCA
Dr Arun Bhatt, Consultant – Clinical Research & Development, advocates the need for collective leadership which focusses on…
The GST GAMBIT
As the deadline for GST roll out nears, the pharma industry is cautiously optimistic about its impact By Prathiba Raju